What question did this study set out to answer?

This review aims to summarize the main challenges in the development of AAV gene therapy and offer strategic solutions.

June 20, 2026Open Access

Six Core Pillars of AAV Gene Therapy Development: Technical, Immunological, and Regulatory Challenges with Strategic Solutions.

View Full Paper

Ask AI

Bookmark

Authors

Minireview highlights AAV development challenges and presents strategic solutions for genomic medicine.

This review aims to summarize the main challenges in the development of AAV gene therapy and offer strategic solutions.
Minireview discussing technical, immunological, and regulatory challenges.
Analysis of emerging solutions such as machine learning-aided design.
Overview of key impediments like capsid tropism and manufacturing scalability.
Identified capsid tropism and pre-existing immunity as significant barriers to broader applications.
Emerging solutions include directed evolution and new purification strategies to overcome these challenges.
Roadmap provided for developing next-generation AAV-based genomic medicines.

Waleed Abdelmaguid (2026) studied this question.

View Full Paper

Ask AI

Bookmark